Clinical Scorecard: Increasing Daily Steps Significantly Reduces Cardiovascular Event Risk in Individuals with Hypertension

At a Glance

Key Highlights

• Each 1000-step/day increase is associated with a 17.1% lower risk of major adverse cardiovascular events (MACE) in hypertensive individuals.
• Higher peak 30-minute stepping cadence independently reduces cardiovascular risk, with benefits observed above 38.3 steps/minute.
• Physical activity and exercise lower blood pressure comparably to antihypertensive medications and improve multiple cardiometabolic risk factors.

Guideline-Based Recommendations

Diagnosis

• Use accelerometers or wearable devices to objectively measure step counts and physical activity in hypertensive patients.

Management

• Encourage adults with hypertension to achieve at least 7000 steps/day, aligning with WHO physical activity guidelines.
• Incorporate moderate-to-vigorous physical activity totaling at least 150 minutes per week, including muscle-strengthening exercises twice weekly.
• Promote various exercise modalities including aerobic, high-intensity interval training, and dynamic resistance training to lower blood pressure.

Monitoring & Follow-up

• Monitor physical activity levels using wearable devices to assess step counts and stepping intensity over time.
• Regularly evaluate blood pressure and cardiovascular risk factors alongside physical activity adherence.

Risks

• Consider limitations in generalizability due to study populations predominantly of White race and higher education levels.
• Recognize that baseline step counts may not reflect long-term activity patterns; ongoing assessment is necessary.

Patient & Prescribing Data

Hypertensive adults without known cardiovascular disease

Increasing daily steps and stepping intensity significantly reduces risk of cardiovascular events, supporting physical activity as a key component of hypertension management.

Clinical Best Practices

• Distinguish between step count, physical activity, and exercise when counseling patients.
• Use objective step count data from wearable devices to overcome biases inherent in self-reported physical activity.
• Advise patients that health benefits accrue even below the 10,000-step goal, with meaningful risk reductions starting at 4000 steps/day.
• Incorporate physical activity promotion as a complement to pharmacologic hypertension treatment.

References

• WHO 2020 Guidelines on Physical Activity and Sedentary Behaviour
• Cheng et al. Study on Step Count and Cardiovascular Events in Hypertension